E-ISSN 1658-8088 | ISSN 1658-807X
 

Original Article 


Supplementary testing after negative or inconclusive exome sequencing results

Balsam AlMaarik, Taghrid Aloraini, Roselyn Paclejan, Mohammed Balwi, Lamia Alsubaie, Abdulrahman Alswaid, Wafaa Eyiad, Fuad Al Mutairi, Faroug Ababneh, Majid Alfadhel, Ahmed A. Alfares.

Abstract
Background: Accurate diagnosis benefits patients and their families by directing clinical management; predicting recurrence risks; providing prognosis; and preventing the invasive, time-consuming, and costly diagnostic odyssey. The present study aimed at evaluating the usefulness and clinical utility of supplementary testing (deletion/duplication, targeted genome methylation analysis, and whole mitochondrial genome testing) after inconclusive or negative exome results and the outcome of the supplementary testing.
Methods: A total of 3,505 clinical exome sequencing results were evaluated, and cases with supplementary testing were analyzed for the accuracy and validity of the supplementary testing.
Results: The present study cohort comprised 26 cases where supplementary testing was ordered (12 inconclusive results and 14 negative results). Out of the 12 inconclusive results, only one case was positive for supplementary testing (1/12) and none of the negative cases (0/14).
Conclusion: For most cases, supplementary testing to negative exome sequencing failed to identify any possible explanation of the disorder, concluding that supplementary testing has limited clinical utility.

Key words: Exome sequencing, deletion duplication, methylation, mitochondrial genome, Saudi Arabia.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Balsam AlMaarik
Articles by Taghrid Aloraini
Articles by Roselyn Paclejan
Articles by Mohammed Balwi
Articles by Lamia Alsubaie
Articles by Abdulrahman Alswaid
Articles by Wafaa Eyiad
Articles by Fuad Al Mutairi
Articles by Faroug Ababneh
Articles by Majid Alfadhel
Articles by Ahmed A. Alfares
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

AlMaarik B, Aloraini T, Paclejan R, Balwi M, Alsubaie L, Alswaid A, Eyiad W, Mutairi FA, Ababneh F, Alfadhel M, Alfares AA. Supplementary testing after negative or inconclusive exome sequencing results. JBCGenetics. 2023; 6(1): 1-13. doi:10.24911/JBCGenetics/183-1659513785


Web Style

AlMaarik B, Aloraini T, Paclejan R, Balwi M, Alsubaie L, Alswaid A, Eyiad W, Mutairi FA, Ababneh F, Alfadhel M, Alfares AA. Supplementary testing after negative or inconclusive exome sequencing results. https://www.jbcgenetics.com//?mno=95398 [Access: August 15, 2023]. doi:10.24911/JBCGenetics/183-1659513785


AMA (American Medical Association) Style

AlMaarik B, Aloraini T, Paclejan R, Balwi M, Alsubaie L, Alswaid A, Eyiad W, Mutairi FA, Ababneh F, Alfadhel M, Alfares AA. Supplementary testing after negative or inconclusive exome sequencing results. JBCGenetics. 2023; 6(1): 1-13. doi:10.24911/JBCGenetics/183-1659513785



Vancouver/ICMJE Style

AlMaarik B, Aloraini T, Paclejan R, Balwi M, Alsubaie L, Alswaid A, Eyiad W, Mutairi FA, Ababneh F, Alfadhel M, Alfares AA. Supplementary testing after negative or inconclusive exome sequencing results. JBCGenetics. (2023), [cited August 15, 2023]; 6(1): 1-13. doi:10.24911/JBCGenetics/183-1659513785



Harvard Style

AlMaarik, B., Aloraini, . T., Paclejan, . R., Balwi, . M., Alsubaie, . L., Alswaid, . A., Eyiad, . W., Mutairi, . F. A., Ababneh, . F., Alfadhel, . M. & Alfares, . A. A. (2023) Supplementary testing after negative or inconclusive exome sequencing results. JBCGenetics, 6 (1), 1-13. doi:10.24911/JBCGenetics/183-1659513785



Turabian Style

AlMaarik, Balsam, Taghrid Aloraini, Roselyn Paclejan, Mohammed Balwi, Lamia Alsubaie, Abdulrahman Alswaid, Wafaa Eyiad, Fuad Al Mutairi, Faroug Ababneh, Majid Alfadhel, and Ahmed A. Alfares. 2023. Supplementary testing after negative or inconclusive exome sequencing results. Journal of Biochemical and Clinical Genetics, 6 (1), 1-13. doi:10.24911/JBCGenetics/183-1659513785



Chicago Style

AlMaarik, Balsam, Taghrid Aloraini, Roselyn Paclejan, Mohammed Balwi, Lamia Alsubaie, Abdulrahman Alswaid, Wafaa Eyiad, Fuad Al Mutairi, Faroug Ababneh, Majid Alfadhel, and Ahmed A. Alfares. "Supplementary testing after negative or inconclusive exome sequencing results." Journal of Biochemical and Clinical Genetics 6 (2023), 1-13. doi:10.24911/JBCGenetics/183-1659513785



MLA (The Modern Language Association) Style

AlMaarik, Balsam, Taghrid Aloraini, Roselyn Paclejan, Mohammed Balwi, Lamia Alsubaie, Abdulrahman Alswaid, Wafaa Eyiad, Fuad Al Mutairi, Faroug Ababneh, Majid Alfadhel, and Ahmed A. Alfares. "Supplementary testing after negative or inconclusive exome sequencing results." Journal of Biochemical and Clinical Genetics 6.1 (2023), 1-13. Print. doi:10.24911/JBCGenetics/183-1659513785



APA (American Psychological Association) Style

AlMaarik, B., Aloraini, . T., Paclejan, . R., Balwi, . M., Alsubaie, . L., Alswaid, . A., Eyiad, . W., Mutairi, . F. A., Ababneh, . F., Alfadhel, . M. & Alfares, . A. A. (2023) Supplementary testing after negative or inconclusive exome sequencing results. Journal of Biochemical and Clinical Genetics, 6 (1), 1-13. doi:10.24911/JBCGenetics/183-1659513785





Most Viewed Articles
  • Frontonasal dysplasia: a review
    Muhammad Umair, Farooq Ahmad, Muhammad Bilal, Muhammad Arshad
    JBCGenetics. 2018; 1(2): 66-76
    » Abstract » doi: 10.24911/JBCGenetics/183-1530765389

  • The role of C-terminal tensin-like (Cten) gene in cancer metastasis
    Saleh Alghamdi, Sarah Alkwai, Mohammad Ilyas
    JBCGenetics. 2018; 1(1): 2-9
    » Abstract » doi: 10.24911/JBCGenetics/183-1531548689

  • Clinical reassessment of post-laboratory variant call format (VCF) files
    Lamia Alsubaie, Saeed Alturki, Ali Alothaim, Ahmed Alfares
    JBCGenetics. 2018; 1(1): 31-36
    » Abstract » doi: 10.24911/JBCGenetics/183-1529928114

  • Microcephalic osteodysplastic primordial dwarfism type II and Klinefelter syndrome: report of two competing growth syndromes
    AlAnoud Al-Jarbou, Afnan Al-Turki, Suha Tashkandi, Eissa A. Faqeih
    JBCGenetics. 2018; 1(1): 37-39
    » Abstract » doi: 10.24911/JBCGenetics/183-1530040885

  • Recessive ARFGEF2 mutation causes progressive microcephaly, epilepsy, and a distinct MRI pattern
    Maram Alojair, Abdulaziz Alghamdi, Kalthoum Tlili, Sateesh Maddirevula, Fowzan Sami Alkuraya, Brahim Tabarki
    JBCGenetics. 2018; 1(1): 40-42
    » Abstract » doi: 10.24911/JBCGenetics/183-1531469195

  • Most Downloaded
  • Frontonasal dysplasia: a review
    Muhammad Umair, Farooq Ahmad, Muhammad Bilal, Muhammad Arshad
    JBCGenetics. 2018; 1(2): 66-76
    » Abstract » doi: 10.24911/JBCGenetics/183-1530765389

  • Generation of a mouse model of Primary Hyperoxaluria Type 1 via CRISPR/Cas9 mediated gene editing
    Kimberly A Coughlan, Rajanikanth J Maganti, Andrea Frassetto, Christine M DeAntonis, meredith Wolfrom, Anne-Renee Graham, Shawn M Hillier, Steven Fortucci, Hoor Al Jandal, Sue-Jean Hong, Paloma H Giangrande, Paolo GV Martini,
    JBCGenetics. 2019; 2(1): 28-39
    » Abstract » doi: 10.24911/JBCGenetics/183-1542047633

  • Syndactyly genes and classification: a mini review
    Muhammad Umair, Farooq Ahmad, Muhammad Bilal, Safdar Abbas
    JBCGenetics. 2018; 1(1): 10-18
    » Abstract » doi: 10.24911/JBCGenetics/183-1532177257

  • Recessive ARFGEF2 mutation causes progressive microcephaly, epilepsy, and a distinct MRI pattern
    Maram Alojair, Abdulaziz Alghamdi, Kalthoum Tlili, Sateesh Maddirevula, Fowzan Sami Alkuraya, Brahim Tabarki
    JBCGenetics. 2018; 1(1): 40-42
    » Abstract » doi: 10.24911/JBCGenetics/183-1531469195

  • Case report of 49, XXXXY syndrome: first case in Oman
    Musallam Said Al Araimi, Salwa Ali AlObaidani, Zainab Al Hashmi, Ruba Al Lawati, Hiba Al Mazrooai Al Mazrooai
    JBCGenetics. 2020; 3(1): 28-31
    » Abstract » doi: 10.24911/JBCGenetics/183-1584426923

  • Most Cited Articles